Avinger Receives FDA Clearance of Pantheris SV Device
April 10, 2019 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., April 10, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of image-guided, catheter-based systems for the diagnosis and treatment of patients with...
Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update
March 06, 2019 16:05 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
Avinger to Announce Fourth Quarter and Full Year 2018 Financial Results on March 6, 2019
February 28, 2019 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided,...
Avinger’s Pantheris SV (Small Vessel) Featured in Live Case Transmission at Leipzig Interventional Course (LINC) 2019
January 28, 2019 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its...
Avinger Announces Preliminary Analysis of Results from SCAN Clinical Study
December 19, 2018 06:00 ET
|
Avinger, Inc.
OCT Imaging with Pantheris Superior or Equivalent to IVUS on all Parameters REDWOOD CITY, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative...
Avinger Announces Successful Treatment of 500th Patient with Next-Generation Pantheris Device
December 13, 2018 07:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...
Avinger Announces Commercial Launch in Australia
December 06, 2018 08:00 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based...
Avinger Announces 510(k) Filing of Pantheris Small Vessel Device
August 30, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the Company...
Avinger Receives New Patent Covering Pantheris Image-Guided Atherectomy System
August 29, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the issuance...
Avinger Announces Participation in Upcoming Investor Conferences
August 28, 2018 08:30 ET
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that...